These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4479573)

  • 1. Lowered aortic impedance as therapy for severe mitral regurgitation.
    Grossman W; Harshaw CW; Munro AB; Becker L; McLaurin LP
    JAMA; 1974 Nov; 230(7):1011-3. PubMed ID: 4479573
    [No Abstract]   [Full Text] [Related]  

  • 2. Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus.
    Chatterjee K; Parmley WW; Swan HJ; Berman G; Forrester J; Marcus HS
    Circulation; 1973 Oct; 48(4):684-90. PubMed ID: 4744778
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of nitroprusside on left ventricular dynamics in mitral regurgitation.
    Goodman DJ; Rossen RM; Holloway EL; Alderman EL; Harrison DC
    Circulation; 1974 Nov; 50(5):1025-32. PubMed ID: 4430088
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of refractory heart failure with infusion of nitroprusside.
    Guiha NH; Cohn JN; Mikulic E; Franciosa JA; Limas CJ
    N Engl J Med; 1974 Sep; 291(12):587-92. PubMed ID: 4855255
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of a patient with severe pulmonary hypertension due to perivalvular leakage at aortic and mitral positions after aortic and mitral valve replacement.
    Miura T; Nishida H; Kawai A; Maeda T; Kurosawa H; Koyanagi H
    Gen Thorac Cardiovasc Surg; 2008 Oct; 56(10):521-5. PubMed ID: 18854932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction.
    Chatterjee K; Parmley WW; Ganz W; Forrester J; Walinsky P; Crexells C; Swan HJ
    Circulation; 1973 Dec; 48(6):1183-93. PubMed ID: 4762476
    [No Abstract]   [Full Text] [Related]  

  • 7. Afterload reduction and cardiac output in patients after mitral valve surgery.
    Appelbaum A; Bitran D; Merin G; Borman JB
    Thorac Cardiovasc Surg; 1980 Dec; 28(6):414-9. PubMed ID: 6162214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and coronary hemodynamic effects of sodium nitroprusside.
    Rowe GG; Henderson RH
    Am Heart J; 1974 Jan; 87(1):83-7. PubMed ID: 4808762
    [No Abstract]   [Full Text] [Related]  

  • 9. Vasodilator drugs in the treatment of hypertension.
    Koch-Weser J
    Arch Intern Med; 1974 Jun; 133(6):1017-27. PubMed ID: 4597950
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug therapy. Sodium nitroprusside.
    Palmer RF; Lasseter KC
    N Engl J Med; 1975 Feb; 292(6):294-7. PubMed ID: 1089194
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic vasodilator therapy in the management of cardiogenic shock and intractable left ventricular failure.
    Cohn JN; Mathew KJ; Franciosa JA; Snow JA
    Ann Intern Med; 1974 Dec; 81(6):777-80. PubMed ID: 4433083
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of intraoperative nitroprusside unloading in mitral and aortic regurgitation.
    Stone JG; Hoar PF; Faltas AN; Johnson LL; Edie RN; Bowman FO; Malm JR
    J Thorac Cardiovasc Surg; 1979 Jul; 78(1):103-9. PubMed ID: 449373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sodium nitroprusside on function in the isolated and intact dog kidney.
    Bastron RD; Kaloyanides GJ
    J Pharmacol Exp Ther; 1972 May; 181(2):244-9. PubMed ID: 5030670
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of intravenous morphine in patients with mitral valvular disease and congestive heart failure.
    Grendahl H; Andersen A; Müller C
    Acta Med Scand; 1973; 1-2(1):69-74. PubMed ID: 4727250
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic effects of noninvasive systolic unloading (nitroprusside) and diastolic augmentation (external counterpulsation) in patients with acute myocardial infarction.
    Parmley WW; Chatterjee K; Charuzi Y; Swan HJ
    Am J Cardiol; 1974 Jun; 33(7):819-25. PubMed ID: 4829364
    [No Abstract]   [Full Text] [Related]  

  • 16. Sodium nitroprusside: a review of its clinical effectiveness as a hypotensive agent.
    Tuzel IH
    J Clin Pharmacol; 1974 Oct; 14(10):494-503. PubMed ID: 4610012
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
    Kieler-Jensen N; Ricksten SE; Stenqvist O; Bergh CH; Lindelöv B; Wennmalm A; Waagstein F; Lundin S
    J Heart Lung Transplant; 1994; 13(3):366-75. PubMed ID: 8061011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable response to inhaled nitric oxide in postoperative patients of mitral stenosis with pulmonary hypertension.
    Razzaq Z; Aslam M; Hussain MM; Naqvi S; Zameer M; Badar A
    J Ayub Med Coll Abbottabad; 2009; 21(1):98-102. PubMed ID: 20364753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nitroglycerin ointment on hemodynamics in patients with mitral insufficiency.
    Gould L; Reddy CV; Zen B; Singh BK
    Angiology; 1980 Oct; 31(10):677-85. PubMed ID: 6778263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N; Lundin S; Ricksten SE
    J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.